Twitter

Archive for January 25th, 2012


Ovarian Cancer Patients with BRCA Mutations May Fare Better than Non-Carriers

A large, multicenter study shows that women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes have better survival rates than women who do not have such mutations. The study is also the first to provide strong evidence that ovarian cancer prognosis is better for women with BRCA2 mutations than women with BRCA1 mutations. The results were published online today in JAMA.

Read More...

More than a Game: Super Bowl Initiative Helps Scientists Study the "Normal" Breast

Connie Rufenbarger has always believed that healthy women would willingly donate breast tissue for research if they were convinced the samples could be used to help find a cure for cancer. Now, she has proof: More than 1,800 women have given breast tissue to the Susan G. Komen for the Cure Tissue Bank at the IU (Indiana University) Simon Cancer Center.

Read More...

Glucarpidase Approved to Lower Toxic Chemotherapy Levels in the Blood

Last week, the Food and Drug Administration (FDA) approved glucarpidase (Voraxaze) to treat patients with toxic levels of the chemotherapy methotrexate (Abitrexate) in their blood.

Read More...

Genetic Abnormality Predicts Treatment Benefit for Patients with Rare Brain Tumor

The addition of chemotherapy to radiation therapy doubled the median survival time for patients with an aggressive form of oligodendroglioma, a rare brain tumor. The patients all had a genetic abnormality known as the 1p19q co-deletion.

Read More...

Stock Show visitors, breast cancer survivors think pink

A woman stands in a boxing ring wearing all white except for her hot-pink boxing gloves, held high, ready for a fight, Schatzman said.

Read More...

Cancer Navigators holiday fundraiser nets more than $18,000

The third annual Holiday Ball 2011 benefit for Cancer Navigators raised more than $18,000 and exceeded previous years’ totals.

Read More...

Roswell Park Makes Major Announcement on Cancer Vaccine

Roswell Park Cancer Institute held a press conference this morning to announce the development of an investigational cancer vaccine.

Read More...

MIT study finds selectively inhibiting PKM2 starves cancer cells:

Crippling a protein that allows cancer cells to grow when oxygen is scarce causes tumors to regress, according to a Massachusetts Institute of Technology study published online on January 23 in the Journal of Experimental Medicine.

Read More...

Study finds many people continue to smoke after being diagnosed with cancer:

A new analysis has found that a substantial number of lung and colorectal cancer patients continue to smoke after being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study provides valuable information on which cancer patients might need help to quit smoking.

Read More...

Women with BRCA1 and BRCA2 mutations survive ovarian cancer at higher rates than those without mutations:

Results from a National Cancer Institute (NCI) sponsored multicenter study published in the Journal of the American Medical Association on January 25, 2012, provides strong evidence that BRCA1 and BRCA2 gene mutation carriers with ovarian cancer were more likely to survive in the five years following diagnosis than were women with ovarian cancer who do not have mutations in these genes.

Read More...